Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skuli, N.
Right arrow Articles by Cohen-Jonathan-Moyal, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skuli, N.
Right arrow Articles by Cohen-Jonathan-Moyal, E.
[Cancer Research 66, 482-489, January 1, 2006]
© 2006 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

Activation of RhoB by Hypoxia Controls Hypoxia-Inducible Factor-1{alpha} Stabilization through Glycogen Synthase Kinase-3 in U87 Glioblastoma Cells

Nicolas Skuli1, Sylvie Monferran1, Caroline Delmas1, Isabelle Lajoie-Mazenc1, Gilles Favre1, Christine Toulas1 and Elizabeth Cohen-Jonathan-Moyal1,2

1 Institut National de la Sante et de la Recherche Medicale U563, Departement d'Innovation Thérapeutique et Oncologie Moléculaire and 2 Departement de Radiothérapie, Centre de Lutte Contre le Cancer Claudius Regaud, Toulouse Cedex, France

Requests for reprints: Elizabeth Cohen-Jonathan-Moyal, Departement de Radiothérapie, Centre de Lutte Contre le Cancer Claudius Regaud, 20-24 rue du Pont St. Pierre, 31052 Toulouse Cedex, France. Phone: 33-5-6142-4178; Fax: 33-5-6142-4643; E-mail: moyal{at}icr.fnclcc.fr or Christine Toulas, INSERM U563, Departement d'Innovation Thérapeutique et Oncologie Moléculaire, Departement de Radiothérapie, Centre de Lutte Contre le Cancer Claudius Regaud, 20-24 rue du Pont St Pierre, 31052 Toulouse Cedex, France. Phone: 33-5-6142-4275; Fax: 33-5-6142-4631; E-mail: toulas{at}icr.fnclcc.fr.

Hypoxia is a crucial factor in tumor aggressiveness and resistance to treatment, particularly in glioma. Our previous results have shown that inhibiting the small GTPase RhoB increased oxygenation of U87 human glioblastoma xenografts, in part, by regulating angiogenesis. We investigated here whether RhoB might also control a signaling pathway that would permit glioma cells to adapt to hypoxia. We first showed that silencing RhoB with siRNA induced degradation and inhibition of the transcriptional activity of the hypoxia-inducible factor by the proteasome in U87 hypoxic cells. This RhoB-dependent degradation of hypoxia-inducible factor-1{alpha} in hypoxic conditions was mediated by the Akt/glycogen synthase kinase-3ß pathway. While investigating how hypoxia could activate this signaling pathway, using the GST-Rhotekin RBD pulldown assay, we showed the early activation of RhoB by reactive oxygen species under hypoxic conditions and, subsequently, its participation in the ensuing cellular adaptation to hypoxia. Overall, therefore, our results have not only highlighted a new signaling pathway for hypoxia controlled by the small GTPase RhoB, but they also strongly implicate RhoB as a potentially important therapeutic target for decreasing tumor hypoxia. (Cancer Res 2006; 66(1): 482-9)




This article has been cited by other articles:


Home page
Cancer Res.Home page
I. Ader, B. Malavaud, and O. Cuvillier
When the Sphingosine Kinase 1/Sphingosine 1-Phosphate Pathway Meets Hypoxia Signaling: New Targets for Cancer Therapy
Cancer Res., May 1, 2009; 69(9): 3723 - 3726.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Skuli, S. Monferran, C. Delmas, G. Favre, J. Bonnet, C. Toulas, and E. Cohen-Jonathan Moyal
{alpha}v{beta}3/{alpha}v{beta}5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
Cancer Res., April 15, 2009; 69(8): 3308 - 3316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Ader, L. Brizuela, P. Bouquerel, B. Malavaud, and O. Cuvillier
Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1{alpha} during Hypoxia in Human Cancer Cells
Cancer Res., October 15, 2008; 68(20): 8635 - 8642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Lajoie-Mazenc, D. Tovar, M. Penary, B. Lortal, S. Allart, C. Favard, M. Brihoum, A. Pradines, and G. Favre
MAP1A Light Chain-2 Interacts with GTP-RhoB to Control Epidermal Growth Factor (EGF)-dependent EGF Receptor Signaling
J. Biol. Chem., February 15, 2008; 283(7): 4155 - 4164.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
M. O. Nowicki, N. Dmitrieva, A. M. Stein, J. L. Cutter, J. Godlewski, Y. Saeki, M. Nita, M. E. Berens, L. M. Sander, H. B. Newton, et al.
Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3
Neuro-oncol, January 1, 2008; 10(5): 690 - 699.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Avivi, L. Brodsky, E. Nevo, and M. R. Band
Differential expression profiling of the blind subterranean mole rat Spalax ehrenbergi superspecies: bioprospecting for hypoxia tolerance
Physiol Genomics, January 12, 2007; 27(1): 54 - 64.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.